Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Express Scripts
Dow
Federal Trade Commission
Fuji
Merck
Farmers Insurance
Johnson and Johnson
Baxter

Generated: February 20, 2018

DrugPatentWatch Database Preview

MESALAMINE Drug Profile

« Back to Dashboard

When do Mesalamine patents expire, and when can generic versions of Mesalamine launch?

Mesalamine is a drug marketed by G And W Labs Inc, Perrigo Israel, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in five NDAs.

The generic ingredient in MESALAMINE is mesalamine. There are twenty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the mesalamine profile page.
Drug patent expirations by year for MESALAMINE
Pharmacology for MESALAMINE
Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Medical Subject Heading (MeSH) Categories for MESALAMINE

US Patents and Regulatory Information for MESALAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc MESALAMINE mesalamine ENEMA;RECTAL 076841-001 Sep 30, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc MESALAMINE mesalamine TABLET, DELAYED RELEASE;ORAL 091640-001 Jun 5, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Israel MESALAMINE mesalamine ENEMA;RECTAL 076751-001 Sep 17, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc MESALAMINE mesalamine SUPPOSITORY;RECTAL 204354-001 Nov 24, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc MESALAMINE mesalamine TABLET, DELAYED RELEASE;ORAL 203286-001 Jul 21, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Baxter
Chinese Patent Office
QuintilesIMS
Teva
UBS
Merck
Julphar
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot